Dose calculation in opioid rotation: electronic calculator vs. manual calculation
- 354 Downloads
Objective To generate, validate and establish a web-based individualised opioid conversion calculator at the University Hospital Basel and to analyse its value and significance. Setting A 700-bed university hospital. Method Published data were screened by a Medline search using the keywords: opioid, rotation, switching, potency and dose ratio. Based on this data, the criteria for the conversion calculator were defined. A prospective process validation was performed prior to the approval. Five months after the introduction of the tool, an online survey was performed in order to evaluate its acceptance by users. In the last step, a manual calculation using a written table was compared with the calculator in a cross-over trial with 72 participants in order to assess the findings of the survey. Results The opioid conversion calculator could be generated for 24 combinations of 6 opioids for 5 different routes of administration. The validation of the calculator was performed successfully without discovering any major or critical defects. The proportion of correct answers increased from 68% using the table to 81% using the calculator (P < 0.001), the median time necessary to answer the ten questions was 8.9 min using the table and 4.8 min using the calculator. Conclusion A web-based opioid conversion calculator was planned, generated, validated and established at the hospital. Based on the results of the online survey and the results of our cross-over trial we conclude that the tool saves time compared to manual calculation and may contribute to patient safety by avoiding calculation errors. With this tool we contribute to the optimisation of processes in hospital and patient safety.
KeywordsChronic pain Opioid rotation Equianalgesic dose ratio (EDR) Opioid conversion calculator Manual calculation Calculation error
We thank all physicians and pain nurses who took time to respond to the online questionnaire. We thank the students who have participated in the study and Christoph Bitter for his support during the study. Furthermore, we thank Allison Dwileski, B.S. (Scientific Secretary, Department of Anaesthesia and Intensive Care Medicine, University Hospital Basel, Basel, Switzerland), for providing editorial assistance.
We thank Janssen Cilag AG, Baar, Switzerland, for support by an unrestricted grant.
Conflicts of interest
The authors have no conflicts of interest to declare.
- 1.Gerbershagen HJ, Dagtekin O, Sabatowski R. Opioide—wann welche Applikationsform? [Opioids—when using which route of administration?] German. Arzneimitteltherapie. 2007;25(10):374–82.Google Scholar
- 2.Eychmüller S. Die Qual der Wahl bei der Therapie mit stark wirksamen Opioiden. Teil 1 von 2. [Therapy with opioids—to be spoilt for choice. Part 1 of 2] German. Prim Care. 2004;4(26):528–31.Google Scholar
- 4.Aeschlimann A, Buettner UW, Desmeules JA, de Stoutz ND, Eychmüller S, Limacher F. Empfehlungen zur Opioidtherapie chronischer Schmerzen. Teil 2. [Recommendations for opioid therapy in chronic pain. Part 2] German. Schweiz Med Forum. 2005;5(44):1107–13.Google Scholar
- 7.Quinn TE. Converting opioid analgesics, Part II: review of equianalgesic conversion calculators. 3rd Revised Version. Pain Relief Connection [Internet]. 2007;6(2) [downloaded June 2008]. Available from URL: http://www2.massgeneral.org/painrelief/pain%20topics/opioid_calculators_v3.07.pdf.
- 8.Eychmüller S. Die Qual der Wahl bei der Therapie mit stark wirksamen Opioiden. Teil 2 von 2. [Therapy with opioids—to be spoilt for choice. Part 2 of 2] German. Prim Care. 2004;4(27–28):561–4.Google Scholar
- 9.Äquivalenzdosen von Opioiden bei Langzeitanwendung. [Equianalgesic doses of opioids in long-term therapy] German. Version 3, 2010 [downloaded July 2010]. Available from URL: http://www.spitalpharmazie-basel.ch/pdf/Aequivalenz_Opioide.pdf.
- 10.Note for guidance on process validation. The European Medicines Agency. CPMP/QWP/848/96 [Internet]. Sept 2001 [downloaded March 2010]. Available from URL: http://www.ema.europa.eu/pdfs/human/qwp/084896en.pdf.
- 12.R Development Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for statistical computing; 2008. ISBN 3-900051-07-0.Google Scholar
- 14.Yan J. Geepack: yet another package for generalized estimating equations. R News 2002;2/3:12–14 [Internet]. Dec 2002 [downloaded July 2010]. Available from URL: http://journal.r-project.org/archive.html.
- 17.Bach V, Kamp-Jensen M, Jensen NH, Eriksen J. Buprenorphine and sustained release morphine—effect and side-effects in chronic use. The Pain Clinic. 1991;4(2):87–93.Google Scholar
- 24.Budd K, Raffa RB (eds). Buprenorphine—the unique opioid analgesic. Stuttgart, New York: Thieme Verlag; 2005. ISBN 3-13-134211-0.Google Scholar
- 27.Plagge H, Bornand D, Ott N, Ruppen W, Vonderschmitt G, Gauggel M, Deuster S. Erstellung und Validierung eines Programms zur Berechnung von Opioid-Äquivalenzdosen. [Generation and validation of an opioid conversion calculator] (Poster) German. In: GSASA-Kongress, Lucerne, Switzerland 2008.Google Scholar
- 32.Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, et al. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract. 2008;8(4):287–313.PubMedCrossRefGoogle Scholar